Advertisement
Australia markets closed
  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     
  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     
  • AUD/USD

    0.6424
    -0.0001 (-0.02%)
     
  • OIL

    82.80
    +0.07 (+0.08%)
     
  • GOLD

    2,405.80
    +7.80 (+0.33%)
     
  • Bitcoin AUD

    100,490.73
    +1,396.73 (+1.41%)
     
  • CMC Crypto 200

    1,385.91
    +73.29 (+5.92%)
     
  • AUD/EUR

    0.6022
    -0.0009 (-0.15%)
     
  • AUD/NZD

    1.0894
    +0.0019 (+0.17%)
     
  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     
  • NASDAQ

    17,184.32
    -209.99 (-1.21%)
     
  • FTSE

    7,895.48
    +18.43 (+0.23%)
     
  • Dow Jones

    37,938.01
    +162.63 (+0.43%)
     
  • DAX

    17,739.35
    -98.05 (-0.55%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

Global CRISPR Technology Industry (2020 to 2027) - Market Trajectory & Analytics

Dublin, May 17, 2021 (GLOBE NEWSWIRE) -- The "CRISPR Technology - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for CRISPR Technology estimated at US$680.3 Million in the year 2020, is projected to reach a revised size of US$2.7 Billion by 2027, growing at a CAGR of 21.8% over the period 2020-2027.

Products, one of the segments analyzed in the report, is projected to record 21.1% CAGR and reach US$1.6 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 22.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $203.2 Million, While China is Forecast to Grow at 21.4% CAGR

The CRISPR Technology market in the U.S. is estimated at US$203.2 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$474.7 Million by the year 2027 trailing a CAGR of 21.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 19.7% and 18.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 15.2% CAGR.

Select Competitors (Total 34 Featured):

  • Agilent Technologies

  • Cellecta, Inc.

  • GeneCopoeia, Inc.

  • GenScript

  • Horizon Discovery Group

  • Integrated DNA Technologies (IDT)

  • Merck KGaA

  • New England Biolabs

  • Origene Technologies, Inc.

  • Synthego Corporation

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights

  • World Market Trajectories

  • Impact of Covid-19 and a Looming Global Recession

ADVERTISEMENT

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

  • UNITED STATES

  • CANADA

  • JAPAN

  • CHINA

  • EUROPE

  • FRANCE

  • GERMANY

  • ITALY

  • UNITED KINGDOM

  • REST OF EUROPE

  • ASIA-PACIFIC

  • REST OF WORLD

IV. COMPETITION

  • Total Companies Profiled: 34

For more information about this report visit https://www.researchandmarkets.com/r/x47kkc

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900